Catalyst Pharmaceuticals, Inc. (CPRX) earnings
CPRX earnings moved a median of -0.29% by the close. Quarterly and annual CPRX reports and results, each read against the price at its own news timestamp. Back to the CPRX overview →
28 measured CPRX earnings events.
Where these CPRX earnings landedvs 28 measured CPRX earnings reactions
| Middle 50% of CPRX earnings reactions | -3.21% to +1.20% |
|---|---|
| Median reaction (to close) | -0.29% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 CPRX earnings events with a measured close landed between -3.21% and +1.20%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results | Press release | +0.00% | -0.06% | |
| Form 10-Q CATALYST PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -0.06% | |
| Catalyst Pharmaceuticals Cancels First Quarter 2026 Conference Call and Webcast | Press release | +0.05% | +0.06% | |
| Form 10-K/A CATALYST PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +0.85% | +2.13% | |
| Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026 | Press release | +1.86% | -0.54% | |
| Form 10-K CATALYST PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -2.01% | +2.18% | |
| Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | -1.03% | -7.04% | |
| Form 10-Q CATALYST PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -1.03% | -7.04% | |
| Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025 | Press release | +0.14% | -2.19% | |
| Form 10-Q CATALYST PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -11.35% | -9.43% | |
| Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025 | Press release | +0.44% | -0.52% | |
| Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update | Press release | -2.97% | +0.75% | |
| Form 10-Q CATALYST PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -2.97% | +0.75% | |
| Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025 | Press release | +0.22% | +0.89% | |
| Form 10-K CATALYST PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +4.57% | -2.96% | |
| Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | -2.06% | -3.96% | |
| Form 10-Q CATALYST PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -2.06% | -3.96% | |
| Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024 | Press release | +0.34% | +2.73% | |
| Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | +0.17% | +4.57% | |
| Form 10-Q CATALYST PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +0.17% | +4.57% | |
| Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024 | Press release | -0.59% | +0.24% | |
| Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update | Press release | -0.81% | +5.25% | |
| Form 10-Q CATALYST PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -0.81% | +5.25% | |
| Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024 | Press release | +0.13% | -1.18% | |
| Form 10-K CATALYST PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -1.90% | -1.66% | |
| Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update | Press release | -4.93% | -7.99% | |
| Form 10-Q CATALYST PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -4.93% | -7.99% | |
| Catalyst Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 8, 2023 | Press release | -1.01% | -1.65% |
Keep exploring
More CPRX: analyst actions → · SEC filings → · CPRX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Jaguar Health, Inc. (JAGX) | 442 | -0.38% | 41% |
| BOVIE MEDICAL (BVX) | 441 | 0.00% | 46% |
| Pacific Biosciences of California, Inc. (PACB) | 440 | -0.29% | 44% |
| EyePoint, Inc. (EYPT) | 439 | -0.25% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.